Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis

Labetalol is used for the therapy of hypertension in preeclampsia. Preeclampsia is characterized by high soluble endoglin (sEng) concentration in plasma and coincides with intrahepatic cholestasis during pregnancy (ICP), which threatens the fetus with the toxicity of cumulating bile acids (BA). Therefore, we hypothesized that both labetalol and increased sEng levels worsen BA cumulation in estrogen-induced cholestasis. C57BL/6J, transgenic mice overexpressing human sEng, and their wild-type littermates were administrated with ethinylestradiol (EE, 10 mg/kg s.c., the mice model of ICP) and labetalol (10 mg/kg s.c.) for 5 days with sample collection and analysis. Plasma was also taken from healthy pregnant women and patients with ICP. Administration of labetalol to mice with EE cholestasis aggravated the increase in BA plasma concentrations by induction of hepatic Mrp4 efflux transporter. Labetalol potentiated the increment of sEng plasma levels induced by estrogen. Increased plasma levels of sEng were also observed in patients with ICP. Moreover, increased plasma levels of human sEng in transgenic mice aggravated estrogen-induced cholestasis in labetalol-treated mice and increased BA concentration in plasma via enhanced reabsorption of BAs in the ileum due to the upregulation of the Asbt transporter. In conclusion, we demonstrated that labetalol increases plasma concentrations of BAs in estrogen-induced cholestasis, and sEng aggravates this retention. Importantly, increased sEng levels in experimental and clinical forms of ICPs might present a novel mechanism explaining the coincidence of ICP with preeclampsia. Our data encourage BA monitoring in the plasma of pregnant women with preeclampsia and labetalol therapy.

[1]  P. Hirsova,et al.  Multidrug Resistance-Associated Protein 2 Deficiency Aggravates Estrogen-Induced Impairment of Bile Acid Metabolomics in Rats , 2022, Frontiers in Physiology.

[2]  P. Pávek,et al.  Metformin impairs bile acid homeostasis in ethinylestradiol-induced cholestasis in mice. , 2021, Chemico-biological interactions.

[3]  S. V. D. van de Graaf,et al.  Molecular regulation of the hepatic bile acid uptake transporter and HBV entry receptor NTCP. , 2021, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[4]  M. Vinken,et al.  Rodent models of cholestatic liver disease: A practical guide for translational research , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[5]  J. López-Novoa,et al.  Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities , 2020, International journal of molecular sciences.

[6]  Jinsong Gao,et al.  Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes and preeclampsia , 2020, Annals of translational medicine.

[7]  R. Hyšpler,et al.  Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver , 2020, International journal of molecular sciences.

[8]  M. Vicen,et al.  Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome , 2020, Cellular and Molecular Life Sciences.

[9]  Na Yang,et al.  ASBT(SLC10A2): A promising target for treatment of diseases and drug discovery. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  Li Chang‐qing,et al.  mir‐22‐3p/KLF6/MMP14 axis in fibro‐adipogenic progenitors regulates fatty infiltration in muscle degeneration , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  H. Kay,et al.  Labetalol-Induced Hepatotoxicity during Pregnancy: A Case Report , 2020, American Journal of Perinatology Reports.

[12]  J. López-Novoa,et al.  Potential Role of Circulating Endoglin in Hypertension via the Upregulated Expression of BMP4 , 2020, Cells.

[13]  E. Hadar,et al.  Intrahepatic cholestasis of pregnancy as a risk factor for preeclampsia , 2020, Archives of Gynecology and Obstetrics.

[14]  P. Malhotra,et al.  Intestinal Absorption of Bile Acids in Health and Disease. , 2019, Comprehensive Physiology.

[15]  R. Hyšpler,et al.  High soluble endoglin levels regulate cholesterol homeostasis and bile acids turnover in the liver of transgenic mice. , 2019, Life sciences.

[16]  Anshul Gupta,et al.  Descriptive Statistics and Normality Tests for Statistical Data , 2019, Annals of cardiac anaesthesia.

[17]  Jingjing Cai,et al.  The management of hypertension in women planning for pregnancy , 2018, British medical bulletin.

[18]  C. Shim,et al.  Ursodeoxycholate Restores Biliary Excretion of Methotrexate in Rats with Ethinyl Estradiol Induced-Cholestasis by Restoring Canalicular Mrp2 Expression , 2018, International journal of molecular sciences.

[19]  J. D. Tebbens,et al.  Soluble endoglin and hypercholesterolemia aggravate endothelial and vessel wall dysfunction in mouse aorta. , 2018, Atherosclerosis.

[20]  E. Cairrão,et al.  Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal , 2018, Journal of cardiovascular development and disease.

[21]  T. Smutny,et al.  Iron depletion induces hepatic secretion of biliary lipids and glutathione in rats. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[22]  G. Dekker,et al.  A retrospective cohort review of intrahepatic cholestasis of pregnancy in a South Australian population. , 2017, European journal of obstetrics, gynecology, and reproductive biology.

[23]  T. Firoz,et al.  Drug-induced fulminant hepatic failure in pregnancy , 2015, Obstetric medicine.

[24]  S. Maslovitz,et al.  Severe intrahepatic cholestasis of pregnancy is a risk factor for preeclampsia in singleton and twin pregnancies. , 2015, American journal of obstetrics and gynecology.

[25]  Huijun Sun,et al.  Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice , 2015, Pharmaceutical Research.

[26]  R. Wong,et al.  Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis , 2015, Journal of cellular and molecular medicine.

[27]  J. V. D. van der Post,et al.  Total bile acids in the maternal and fetal compartment in relation to placental ABCG2 expression in preeclamptic pregnancies complicated by HELLP syndrome. , 2015, Biochimica et biophysica acta.

[28]  V. Geenes,et al.  Intrahepatic Cholestasis of Pregnancy , 2014, Obstetrics and gynecology.

[29]  F. Blanco,et al.  Oxysterol-Induced Soluble Endoglin Release and Its Involvement in Hypertension , 2012, Circulation.

[30]  S. Tsuchida,et al.  Sustained repression and translocation of Ntcp and expression of Mrp4 for cholestasis after rat 90% partial hepatectomy. , 2011, Journal of hepatology.

[31]  R. Weiskirchen,et al.  Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling. , 2011, Cellular signalling.

[32]  J. López-Novoa,et al.  The physiological role of endoglin in the cardiovascular system. , 2010, American journal of physiology. Heart and circulatory physiology.

[33]  H. Verspaget,et al.  Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. , 2010, Cancer research.

[34]  T. Libermann,et al.  Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.

[35]  J. Boyer,et al.  Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis , 2006, Hepatology.

[36]  K. Aittomäki,et al.  Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: A population‐based study , 2006, Hepatology.

[37]  D. Keppler,et al.  Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis , 2005, Hepatology.

[38]  L. Mattsson,et al.  Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates , 2004, Hepatology.

[39]  M. Anwer Cellular regulation of hepatic bile acid transport in health and cholestasis , 2004, Hepatology.

[40]  J. Boyer,et al.  Bile salt transporters: molecular characterization, function, and regulation. , 2003, Physiological reviews.

[41]  J. Marin,et al.  Relationship between asymptomatic hypercholanaemia of pregnancy and progesterone metabolism. , 2002, Clinical science.

[42]  M. Letarte,et al.  Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells. , 1994, Endocrinology.

[43]  M. Letarte,et al.  Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. , 1990, The Journal of biological chemistry.

[44]  T. Okuyama,et al.  Protective effects of adrenoceptor-blocking agents on myocardial injury induced by epinephrine in mice. , 1990, The Journal of toxicological sciences.

[45]  P. Ylöstalo,et al.  CHANGES IN SERUM BILE ACID CONCENTRATIONS DURING NORMAL PREGNANCY, IN PATIENTS WITH INTRAHEPATIC CHOLESTASIS OF PREGNANCY AND IN PREGNANT WOMEN WITH ITCHING , 1981, British journal of obstetrics and gynaecology.

[46]  D. Cova,et al.  Effects of ethinyl estradiol on bile secretion and liver microsomal mixed function oxidase system in the mouse. , 1980, Biochemical pharmacology.